Fig. 5: Transplantation of TPBG+ vmDA precursors into rodent PD models. | npj Parkinson's Disease

Fig. 5: Transplantation of TPBG+ vmDA precursors into rodent PD models.

From: Trophoblast glycoprotein is a marker for efficient sorting of ventral mesencephalic dopaminergic precursors derived from human pluripotent stem cells

Fig. 5

a At 16 weeks after transplantation, the TPBG+ vmDA precursor grafts within the host striatum were visualized by hNCAM staining. b Graft volume of each group (unsorted, TPBG+, and TPBG) based on immunostaining for hNCAM normalized to 100,000 grafted cells. c DA density in grafts from each group (TH+ cells/mm3). d–g Expression of hNCAM (green), Ki67 (red), TH (red), NURR1 (red), and PITX3 (red) in grafts containing TPBG+ cells at 16 weeks after transplantation. DAPI (blue) was used as a counterstain. Quantification of Ki67+, TH+, NURR1+, and PITX3+ cells in the grafts containing unsorted cells (n = 3), eGFP+ cells (LMX1A+ cells; n = 3), eGFP cells (LMX1A cells; n = 4), TPBG+ cells (n = 4), and TPBG cells (n = 4) at 16 weeks. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Bonferroni’s multiple-comparison tests. h Amphetamine-induced rotation tests (Non-PD group, n = 3, vehicle, n = 6; unsorted, n = 3; eGFP+, n = 6; eGFP, n = 4; TPBG+, n = 4; TPBG, n = 4) one week before (left panel) and 16 weeks after (right panel) cell transplantation. **p < 0.01, unpaired Student’s t-tests. Data are shown as mean ± SD. Scale bar, 25 µm (dg).

Back to article page